Nathan Gracey
Medical · Garden City, UTNPI 1255597043
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 264 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 264 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$770
- Boehringer Ingelheim$463
- AstraZeneca$451
- Novartis$446
- Bayer$339
- AbbVie$273
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,467100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 44 | $770 |
| Boehringer Ingelheim | 30 | $463 |
| AstraZeneca | 18 | $451 |
| Novartis | 28 | $446 |
| Bayer | 22 | $339 |
| AbbVie | 19 | $273 |
| Pfizer | 14 | $237 |
| Novo Nordisk | 15 | $236 |
| Amarin Pharma, Inc. | 11 | $167 |
| Medtronic | 7 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $113 |
| Abbott | 5 | $97 |
| Johnson & Johnson | 6 | $81 |
| Paratek Pharmaceuticals, Inc. | 4 | $73 |
| Lilly USA, LLC | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 1 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Medicure Pharma Inc. | 1 | $39 |
| Dexcom, Inc. | 2 | $37 |
| Corcept Therapeutics | 3 | $37 |
| Biogen | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Eisai Inc. | 2 | $26 |
| Lundbeck LLC | 1 | $24 |
| Lucid Diagnostics Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Renalytix AI, Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$4,467 in reported general payments places this provider in the 85th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 52 | $59,869 |
| JardianceEmpagliflozin | 52 | $51,760 |
| MounjaroTirzepatide | 44 | $50,891 |
| XareltoRivaroxaban | 74 | $49,655 |
| EliquisApixaban | 47 | $42,330 |
| KerendiaFinerenone | 19 | $21,326 |
| MyrbetriqMirabegron | 24 | $16,194 |
| TrulicityDulaglutide | 13 | $13,487 |
| GemtesaVibegron | 22 | $10,623 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $8,505 |
| Repatha SyringeEvolocumab | 11 | $3,899 |
| VascepaIcosapent Ethyl | 14 | $3,771 |
| Omeprazole | 126 | $3,177 |
| Celecoxib | 76 | $2,777 |
| Atorvastatin Calcium | 248 | $2,687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $60 | $64,37857 claims |
| Novo NordiskOzempic | $236 | $59,86952 claims |
| Boehringer IngelheimJardiance | $463 | $51,76052 claims |
| Johnson & JohnsonXarelto | $81 | $49,65574 claims |
| PfizerEliquis | $237 | $42,33047 claims |
| BayerKerendia | $339 | $21,32619 claims |
| MerckJanumet | $11 | $8,50515 claims |
| AbbVieSynthroid | $273 | $1,33717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 263 medical providers in Utah.
Other medical in Garden City
- Elisa WilcoxSalt Lake City$178K
- Val WarnerLayton$51K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
- Mark UdySt George$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.